IHI vs. SPY
IHI (iShares U.S. Medical Devices ETF) and SPY (State Street SPDR S&P 500 ETF) are both exchange-traded funds - IHI is a Health & Biotech Equities fund tracking the Dow Jones U.S. Select Medical Equipment Index, while SPY is a S&P 500 fund tracking the S&P 500 Index. Both are passively managed. Over the past 10 years, IHI returned 8.71%/yr vs 15.70%/yr for SPY. A 0.75 correlation means they provide meaningful diversification when combined. IHI charges 0.38%/yr vs 0.09%/yr for SPY.
Performance
IHI vs. SPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IHI achieves a -22.04% return, which is significantly lower than SPY's 9.74% return. Over the past 10 years, IHI has underperformed SPY with an annualized return of 8.71%, while SPY has yielded a comparatively higher 15.70% annualized return.
IHI
- 1D
- -1.49%
- 1M
- -4.26%
- YTD
- -22.04%
- 6M
- -23.22%
- 1Y
- -19.49%
- 3Y*
- -4.08%
- 5Y*
- -3.72%
- 10Y*
- 8.71%
SPY
- 1D
- -0.31%
- 1M
- 0.09%
- YTD
- 9.74%
- 6M
- 9.27%
- 1Y
- 26.65%
- 3Y*
- 21.27%
- 5Y*
- 13.51%
- 10Y*
- 15.70%
IHI vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IHI iShares U.S. Medical Devices ETF | -22.04% | 6.88% | 8.62% | 3.24% | -19.80% | 21.03% | 24.17% | 32.75% | 15.45% | 30.81% |
SPY State Street SPDR S&P 500 ETF | 9.74% | 17.72% | 24.89% | 26.18% | -18.18% | 28.73% | 18.33% | 31.22% | -4.57% | 21.71% |
Correlation
The correlation between IHI and SPY is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.55 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.66 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.71 |
Correlation (All Time) Calculated using the full available price history since May 5, 2006 | 0.75 |
Over the past year, the correlation between IHI and SPY has dropped to 0.43 - well below their long-term average of 0.75, suggesting their price drivers have been diverging.
IHI vs. SPY - Sectors Allocation Comparison
Sectors
IHI
SPY
Healthcare
Industrials
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
IHI
SPY
Industrials
IHI
SPY
Basic Materials
IHI
-
SPY
Communication Services
IHI
-
SPY
Consumer Cyclical
IHI
-
SPY
Consumer Defensive
IHI
-
SPY
Energy
IHI
-
SPY
Financial Services
IHI
-
SPY
Real Estate
IHI
-
SPY
Technology
IHI
-
SPY
Utilities
IHI
-
SPY
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IHI vs. SPY — Risk / Return Rank
IHI
SPY
IHI vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Medical Devices ETF (IHI) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IHI | SPY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.27 | ||
| Sortino ratioReturn per unit of downside risk | -4.45 | ||
| Omega ratioGain probability vs. loss probability | 0.83 | 1.39 | -0.56 |
| Calmar ratioReturn relative to maximum drawdown | -0.75 | 3.01 | -3.76 |
| Martin ratioReturn relative to average drawdown | -1.72 | 13.54 | -15.26 |
Loading charts...
Drawdowns
IHI vs. SPY - Drawdown Comparison
The maximum IHI drawdown since its inception was -49.65%, smaller than the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for IHI and SPY.
Loading charts...
Drawdown Indicators
| IHI | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -49.65% | -55.19% | +5.54% |
Max Drawdown (1Y)Largest decline over 1 year | -26.11% | -8.88% | -17.23% |
Max Drawdown (3Y)Largest decline over 3 years | -26.64% | -18.76% | -7.88% |
Max Drawdown (5Y)Largest decline over 5 years | -33.12% | -24.50% | -8.62% |
Max Drawdown (10Y)Largest decline over 10 years | -33.25% | -33.72% | +0.47% |
Current DrawdownCurrent decline from peak | -26.39% | -1.75% | -24.64% |
Average DrawdownAverage peak-to-trough decline | -8.35% | -9.04% | +0.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.34% | 1.97% | +9.37% |
Volatility
IHI vs. SPY - Volatility Comparison
iShares U.S. Medical Devices ETF (IHI) has a higher volatility of 6.52% compared to State Street SPDR S&P 500 ETF (SPY) at 4.64%. This indicates that IHI's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IHI | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.52% | 4.64% | +1.88% |
Volatility (6M)Calculated over the trailing 6-month period | 13.71% | 9.75% | +3.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.57% | 12.43% | +5.14% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.07% | 17.14% | +1.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.84% | 17.99% | +1.85% |
IHI vs. SPY - Expense Ratio Comparison
IHI has a 0.38% expense ratio, which is higher than SPY's 0.09% expense ratio.
Dividends
IHI vs. SPY - Dividend Comparison
IHI's dividend yield for the trailing twelve months is around 0.50%, less than SPY's 1.01% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHI iShares U.S. Medical Devices ETF | 0.50% | 0.34% | 0.46% | 0.53% | 0.45% | 0.25% | 0.25% | 0.33% | 0.26% | 0.37% | 0.55% | 1.28% |
SPY State Street SPDR S&P 500 ETF | 1.01% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
Frequently Asked Questions
IHI and SPY have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IHI has higher volatility (6.52%) compared to SPY (4.64%). In terms of maximum drawdown, IHI dropped -49.65% vs SPY's -55.19%.
On 10-year performance, SPY leads with 15.70% vs 8.71% for IHI. On fees, SPY is cheaper at 0.09% per year. On volatility, SPY has been the lower-risk option at 4.64%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SPY has performed better with a 15.70% return vs 8.71%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SPY is cheaper with a 0.09% expense ratio, compared with 0.38% for IHI.
SPY has the higher dividend yield at 1.01%, compared with 0.50% for IHI.
IHI is categorized as Health & Biotech Equities, while SPY is S&P 500. IHI tracks Dow Jones U.S. Select Medical Equipment Index, while SPY tracks S&P 500 Index. They also come from different issuers: iShares and State Street. Their fees differ too: 0.38% for IHI and 0.09% for SPY.
SPY currently has the higher Sharpe Ratio (2.16 vs -1.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IHI and SPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer